Comparison of neurovirulent and attenuated poliovirus genomes has implicated the 5' noncoding region of the viral RNA in a rate limiting step in viral growth and neurovirulence. The poliovirus 5' noncoding region presumably contains signals important for the translation and amplification of the viral RNA genome. The availability of an infectious cDNA clone of the viral genome and the discovery that in vitro synthesized viral RNA is infectious when introduced into mammalian cells, allow the application of genetics to study this RNA virus.
The aim of this proposal is to introduce defined mutations into the 5' noncoding region by site- directed mutagenesis of the cDNA and to study their effects on the translation and amplification of the viral RNA genome. Specifically, we will analyze wild type and mutant RNA molecules in in vitro translation and replication systems. Hybrid genes containing the 5' noncoding region of wild type or altered viral genomes and the coding region of a test gene will be constructed and the translatability of the hybrid mRNAs will be tested in cell lines harbouring the hybrid genes stably integrated in the chromosome. In addition, we will search for trans-acting factors which might interact with the 5' noncoding region. These studies will be complemented by the structural analysis of wild type and mutant 5' noncoding regions employing RNA-conformation specific chemical probes and reverse transcriptase. The recent sequencing of other picornavirus RNA genomes has revealed great homology in the 5' noncoding region. Thus, knowledge of the structure and function of this region will increase our understanding of the neurovirulent behaviour of other medically important RNA viruses such as Theiler's virus, a neurotropic mouse RNA virus, which is studied extensively in the laboratories of Drs. Murray and Rotbart at the University of Colorado Health Sciences Center.

Project Start
Project End
Budget Start
Budget End
Support Year
7
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Colorado Denver
Department
Type
DUNS #
065391526
City
Aurora
State
CO
Country
United States
Zip Code
80045
Cohrs, Randall J; Lee, Katherine S; Beach, Addilynn et al. (2017) Targeted Genome Sequencing Reveals Varicella-Zoster Virus Open Reading Frame 12 Deletion. J Virol 91:
Ouwendijk, Werner J D; van Veen, Suzanne; Mahalingam, Ravi et al. (2017) Simian varicella virus inhibits the interferon gamma signalling pathway. J Gen Virol :
Ouwendijk, Werner J D; Getu, Sarah; Mahalingam, Ravi et al. (2016) Characterization of the immune response in ganglia after primary simian varicella virus infection. J Neurovirol 22:376-88
Birlea, Marius; Owens, Gregory P; Eshleman, Emily M et al. (2013) Human anti-varicella-zoster virus (VZV) recombinant monoclonal antibody produced after Zostavax immunization recognizes the gH/gL complex and neutralizes VZV infection. J Virol 87:415-21
Mueller, Niklaus H; Bos, Nathan L; Seitz, Scott et al. (2012) Recombinant monoclonal antibody recognizes a unique epitope on varicella-zoster virus immediate-early 63 protein. J Virol 86:6345-9
Nagel, Maria A; Bert, Robert J; Gilden, Don (2012) Raeder syndrome produced by extension of chronic inflammation to the internal carotid artery. Neurology 79:1296-7
Wolf, James; Nagel, Maria A; Mahalingam, Ravi et al. (2012) Chronic active varicella zoster virus infection. Neurology 79:828-9
Brennan, Kathryn M; Galban-Horcajo, Francesc; Rinaldi, Simon et al. (2011) Lipid arrays identify myelin-derived lipids and lipid complexes as prominent targets for oligoclonal band antibodies in multiple sclerosis. J Neuroimmunol 238:87-95
Haug, Aaron; Mahalingam, Ravi; Cohrs, Randall J et al. (2010) Recurrent polymorphonuclear pleocytosis with increased red blood cells caused by varicella zoster virus infection of the central nervous system: Case report and review of the literature. J Neurol Sci 292:85-8
Mahalingam, Ravi; Traina-Dorge, Vicki; Wellish, Mary et al. (2010) Latent simian varicella virus reactivates in monkeys treated with tacrolimus with or without exposure to irradiation. J Neurovirol 16:342-54

Showing the most recent 10 out of 146 publications